Çocuk ve Ergenlerde İrritabilite ve Agresyon

Toohey MJ, DiGiuseppe R. Defining and measuring irritability: Construct clarification and differentiation. Clin Psychol Rev 2017;53(4):93-108.

Copeland WE, Brotman MA, Costello EJ. Normative irritability in youth: Developmental findings from the Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry 2015;54(8):635-42.

Vidal-Ribas P. Editorial: Moving from concept to proof in the distinction between phasic and tonic irritability. J Am Acad Child Adolesc Psychiatry 2021;60(12):1464-66.

Leibenluft E. Pediatric irritability: A systems neuroscience approach. Trends Cogn Sci 2017;21(4):277-89.

Blader JC. Attention-deficit hyperactivity disorder and the dysregulation of emotion generation and emotional expression. Child Adolesc Psychiatr Clin N Am 2021;30(2):349-60.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.

Carlson GA, Singh MK, Amaya-Jackson L, et al. Narrative review: impairing emotional outbursts: what they are and what we should do about them. J Am Acad Child Adolesc Psychiatry 2023;62(2):135-50.

Copeland WE, Angold A, Costello EJ, Egger H. Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatry 2013;170(2):173-79.

Potegal M, Kosorok MR, Davidson RJ. Temper tantrums in young children: 2.Tantrum duration and temporal organization. J Dev Behav Pediatr 2003;24(3):148-54.

Wiggins JL, Briggs-Gowan MJ, Brotman MA, Leibenluft E, Wakschlag LS. Toward a developmental nosology for disruptive mood dysregulation disorder in early childhood. J Am Acad Child Adolesc Psychiatry 2021;60(3):388-97.

Allen JJ, Anderson CA, Bushman BJ. The general aggression model. Curr Opin Psychol 2018;19(2):75-80.

Raine A, Dodge K, Loeber R, et al. The Reactive-Proactive Aggression Questionnaire: Differential correlates of reactive and proactive aggression in adolescent boys. Aggress Behav 2006;32(2):159-71.

Youngstrom EA, Young AS, Van Eck K, et al. Developing empirical latent profiles of impulsive aggression and mood in youths across three outpatient samples. J Clin Child Adolesc Psychol 2023;52(2):196-211.

Stringaris A, Vidal-Ribas P, Brotman MA, Leibenluft E. Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people. J Child Psychol Psychiatry 2018;59(7):721-39.

Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003;160(3):430-37.

Brotman MA, Schmajuk M, Rich BA, et al. Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biol Psychiatry 2006;60(9):991-7.

Harvey EA, Youngwirth SD, Thakar DA, et al. Predicting attention-deficit/hyperactivity disorder and oppositional defiant disorder from preschool diagnostic assessments. J Consult Clin Psychol 2009;77(2):349.

Hakulinen C, Jokela M, Hintsanen M, et al. Childhood family factors predict developmental trajectories of hostility and anger: a prospective study from childhood into middle adulthood. Psychol Med 2013;43(11):2417-26.

Althoff RR, Crehan ET, He JP, et al. Disruptive mood dysregulation disorder at ages 13–18: results from the National Comorbidity Survey–Adolescent Supplement. J Child Adolesc Psychopharmacol 2016;26(2):107-13.

World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics. 11th Revision. Lyon: World Health Organization; 2018.

Evans SC, Burke JD, Roberts MC, et al. Irritability in child and adolescent psychopathology: An integrative review for ICD-11. Clin Psychol Rev 2017;53(4):29-45.

Evans SC, Roberts MC, Keeley JW, et al. Diagnostic classification of irritability and oppositionality in youth: A global field study comparing ICD-11 with ICD-10 and DSM-5. J Clin Psychol Psychiatry 2021;62(3):303-12.

Stringaris A, Goodman R. Three dimensions of oppositionality in youth. J Child Psychol Psychiatry 2009;50(3):216-23.

Burke JD, Rowe R, Boylan K. Functional outcomes of child and adolescent ODD in young adult men. J Child Psychol Psychiatry 2014;55(3):264-72.

Mayes SD, Waxmonsky JD, Calhoun SL. Bixler EO. Disruptive mood dysregulation disorder symptoms and association with oppositional defiant and other disorders in a general population child sample. J Child Adolesc Psychopharmacol 2016;26(2):101-16.

Wiggins JL, Briggs-Gowan MJ, Brotman MA, et al. Don’t miss the boat: towards a developmental nosology for disruptive mood dysregulation disorder in early childhood. J Am Acad Child Adolesc Psychiatry 2020;60(3):388–97.

Burke JD, Boylan K, Rowe R, et al. Identifying the irritability dimension of ODD: application of a modified bifactor model across five large community samples of children. J Abnormal Psychol 2014;123(4):841.

Herzhoff K, Tackett JL. Subfactors of oppositional defiant disorder: converging evidence from structural and latent class analyses. J Child Psychol Psychiatry 2016;57(1):18-29.

Johnston OG, Cruess DG, Burke JD. Irritability and behavioral symptom dimensions of oppositional defiant disorder in young adults: associations with DSM-5 pathological personality traits. J Psychopathol Behav Assess 2020;42(3):424-35.

Burke JD, Johnston OG, Butler EJ. The irritable and oppositional dimensions of oppositional defiant disorder: Integral factors in the explanation of affective and behavioral psychopathology. Child Adolesc Psychiatr Clin N Am 2021;30(3):637-47.

Leibenluft E, Kircanski K. Chronic irritability in youth: A reprise on challenges and opportunities toward meeting unmet clinical needs. Child Adolesc Psychiatr Clin N Am 2021;30(3):667-83.

Herpers PC, Rommelse NN, Bons DM, et al. Callous–unemotional traits as a cross-disorders construct. Soc Psychiatry Psychiatr Epidemiol 2012;47:2045-64.

Lin YJ, Tseng WL, Gau SSF. Psychiatric comorbidity and social adjustment difficulties in children with disruptive mood dysregulation disorder: A national epidemiological study. J Affect Disord 2021;281(2):485-92.

Mayes SD, Calhoun SL, Waxmonsky JG, et al. Demographic differences in disruptive mood dysregulation disorder symptoms in ADHD, autism, and general population samples. J Atten Disord 2019;23(8):849-58.

Leibenluft E, Uher R, Rutter M. Disruptive mood dysregulation with dysphoria disorder: a proposal for ICD-11 World Psychiatry 2012;11(Suppl 1):77-81.

Roy AK, Lopes V, Klein RG. Disruptive mood dysregulation disorder: a new diagnostic approach to chronic irritabilit in youth. Am J Psychiatry 2014;171(9):918-24.

McLaughlin KA, Green JG, Hwang I, et al. Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 2012;69(11):1131-39.

Radwan K, Coccaro EF. Comorbidity of disruptive behavior disorders and intermittent explosive disorder. Child Adolesc Psychiatry Ment Health 2020;14(24):1-10.

Gelegen V, Tamam L. Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients. Compr Psychiatry 2018;83(5):64-70.

Coccaro EF. DSM-5 intermittent explosive disorder: relationship with disruptive mood dysregulation disorder. Compr Psychiatry 2018;84(7):118-21.

Kessler RC, Avenevoli S, McLaughlin KA, et al. Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Medicine 2012;42(9):1997-2010.

Cardinale EM, Freitag GF, Brotman MA, et al. Phasic versus tonic irritability: Differential associations with attention-deficit/hyperactivity disorder symptoms. J Am Acad Child Adolesc Psychiatry 2021;60(12):1513-23.

Faraone SV, Rostain AL, Blader J, et al. Practitioner review: Emotional dysregulation in attention-deficit/hyperactivity disorder—implications for clinical recognition and intervention. J Child Psychol Psychiatry. 2019;60(2):133-150.

Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry. 2014;171(3):276-93.

Blair RJR.Traits of empathy and anger: implications for psychopathy and other disorders associated with aggression. Phil Trans R Soc 2018;373(1744):20170155.

Crapanzano AM, Frick PJ, Terranova AM. Patterns of Physical and Relational Aggression in a School-Based Sample of Boys and Girls. J Abnorm Child Psychol 2010; 38, 433-45.

Burke JD, Waldman I, Lahey BB. Predictive validity of childhood oppositional defiant disorder and conduct disorder: implications for DSM-V. J Abnormal Psychol 2010;119(4):739-51.

Frick PJ, Ray JV, Thornton LC, Kahn RE. Can callous-unemotional traits enhance the understanding, diagnosis, and treatment of serious conduct problems in children and adolescents? A comprehensive review. Psychol Bull 2014;140(1):1.

Frick PJ, Ray JV, Thornton LC, Kahn RE. Annual research review: a developmental psychopathology approach to understanding callous-unemotional traits in children and adolescents with serious conduct problems. J Child Psychol Psychiatry 2014;55(6):532-48.

Hawes DJ, Dadds MR, Brennan J, Rhodes T, Cauchi A. Revisiting the treatment of conduct problems in children with callous-unemotional traits. Aust N Z J Psychiatry 2013;47(7):646-53.

Colins OF, Van Damme L, Fanti KA, Andershed H. The prospective usefulness of callous-unemotional traits and conduct disorder in predicting treatment engagement among detained girls. Eur Child Adolesc Psychiatry 2017; 26:75-85.

Ackermann K, Kirchner M, Bernhard A, et al. Relational aggression in adolescents with conduct disorder: Sex differences and behavioral correlates. J Abnorm Child Psychol 2019;47:1625-1637.

Judd LL, Schettler PJ, Coryell W, Akiskal HS, Fiedorowicz JG. Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course. JAMA Psychiatry 2013;70(11):1171-80.

Fava M, Hwang I, Rush AJ, et al. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010;15(8):856-67.

Krieger FV, Polanczyk GV, Goodman R, et al. Dimensions of oppositionality in a Brazilian community sample: testing the DSM-5 proposal and etiological links. J Am Acad Child Adolesc Psychiatry 2013;52(4):389-400.

Ezpeleta L, Granero R, De La Osa N, et al. Dimensions of oppositional defiant disorder in 3-year-old preschoolers. J Child Psychol Psychiatry 2012;53(11):1128-38.

Ezpeleta L, Granero R, de la Osa N, et al. Trajectories of oppositional defiant disorder irritability symptoms in preschool children. J Abnormal Child Psychol 2016;44(1):115-28.

Boylan K, Rowe R, Duku E, et al. Longitudinal profiles of girls’ irritable, defiant and antagonistic oppositional symptoms: evidence for group based differences in symptom severity. J Abnormal Child Psychol 2017;45(6):1133-45.

Riglin L, Eyre O, Thapar AK, et al. Identifying novel types of irritability using a developmental genetic approach. Am J Psychiatry 2019;176(8):635-42.

Caprara GV, Paciello M, Gerbino M, et al. Individual differences conducive to aggression and violence: trajectories and correlates of irritability and hostile rumination through adolescence. Aggressive Behav 2007;33(4):359-74.

Wesselhoeft R, Stringaris A, Sibbersen C, et al. Dimensions and subtypes of oppositionality and their relation to comorbidity and psychosocial characteristics. Eur Child Adolesc Psychiatry 2019;28(3):351-65.

Achenbach TM, Ivanova MY, Rescorla LA, Turner LV, Althoff RR. Internalizing/ Externalizing problems: Review and recommendations for clinical and research applications. J Am Acad Child Adolesc Psychiatry 2016;55(8):647-56.

Caspi A, Moffitt TE. All for one and one for all: Mental disorders in one dimension. Am J Psychiatry 2018;175(9):831-44.

Coccaro EF, Bergeman CS, Kavoussi RJ, Seroczynski AD. Heritability of aggression and irritability: a twin study of the Buss-Durkee aggression scales in adult male subjects. Biol Psychiatry 1997;41(3):273-84.

Eley TC. Behavioral genetics as a tool for developmental psychology: anxiety and depression in children and adolescents. Clin Child Fam Psychol Rev 1999;2:21-36.

Roberson-Nay R, Leibenluft E, Brotman MA, et al. Longitudinal stability of genetic and environmental influences on irritability: from childhood to young adulthood. Am J Psychiatry 2015;172(7):657-64.

Savage J, Verhulst B, Copeland W, et al. A genetically informed study of the longitudinal relation between irritability and anxious/depressed symptoms. J Am Acad Child Adolesc Psychiatry 2015;54(5):377-84.

Whelan YM, Leibenluft E, Stringaris A, Barker ED. Pathways from maternal depressive symptoms to adolescent depressive symptoms: the unique contribution of irritability symptoms. J Child Psychol Psychiatry 2015;56(10):1092-100.

Wiggins JL, Mitchell C, Stringaris A, Leibenluft E. 2014. Developmental trajectories of irritability and bidirectional associations with maternal depression. J Am Acad Child Adolesc Psychiatry 2014;53(11):1191-205.

Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med 2020;12:44.

Moore AA, Lapato DM, Brotman MA, et al. Heritability, stability, and prevalence of tonic and phasic irritability as indicators of disruptive mood dysregulation disorder. J Child Psychol Psychiatry 2019;60(9):1032-41.

Perepletchikova F, Nathanson D, Axelrod SR, et al. Randomized clinical trial of dialectical behavior therapy for preadolescent children with disruptive mood dysregulation disorder: feasibility and outcomes. J Am Acad Child Adolesc Psychiatry 2017;56(10):832-40.

Blair RJ. Psychopathy, frustration, and reactive aggression: the role of ventromedial prefrontal cortex. Brit J Psychol 2010;101(3):383-99.

Adleman NE, Kayser R, Dickstein D, et al. Neural correlates of reversal learning in severe mood dysregulation and pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2011;50(11):1173-85.

Finger EC, Marsh AA, Blair KS, et al. Disrupted reinforcement signaling in the orbitofrontal cortex and caudate in youths with conduct disorder or oppositional defiant disorder and a high level of psychopathic traits. Am J Psychiatry 2011;168(2):152-62.

Cools R, Clark L, Owen AM, Robbins TW. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 2002;22(11):4563-67.

Nakamura K, Hikosaka O. Role of dopamine in the primate caudate nucleus in reward modulation of saccades. J Neurosci 2006;26(20):5360-69.

Gatzke-Kopp LM, Beauchaine TP, Shannon KE, et al. Neurological correlates of reward responding in adolescents with and without externalizing behavior disorders. J Abnorm Psychol 2009;118(1):203-13.

Guyer AE, McClure EB, Adler AD, et al. Specificity of facial expression labeling deficits in childhood psychopathology. J Child Psychol Psychiatry 2007;48(9):863-71.

Deveney CM, Connolly ME, Haring CT, et al. Neural mechanisms of frustration in chronically irritable children. Am J Psychiatry 2013;170(10):1186-94.

Thomas LA, Brotman MA, Muhrer EJ, et al. Parametric modulation of neural activity by emotion in youth with bipolar disorder, youth with severe mood dysregulation, and healthy volunteers. Arch Gen Psychiatry 2012;69(12):1257-66.

Wiggins JL, Brotman MA, Adleman NE, et al. Neural correlates of irritability in disruptive mood dysregulation and bipolar disorders. Am J Psychiatry 2016;173(7):722-30.

Rich BA, Carver FW, Holroyd T, et al. Different neural pathways to negative affect in youth with pediatric bipolar disorder and severe mood dysregulation. J Psychiatr Res 2011;45(10):1283-94.

Uran P, Kilic B. Comparison of neuropsychological performances and behavioral patterns of children with attention deficit hyperactivity disorder and severe mood dysregulation. Eur Child Adolesc Psychiatry 2015;24(1):21-30.

Meyers E, DeSerisy M, Roy A. Disruptive mood dysregulation disorder (DMDD): An RDoC perspective. J Affect Disord 2017;216(7):117-22.

Bérubé A, Turgeon J, Blais C, Fiset D. Emotion recognition in adults with a history of childhood maltreatment: A systematic review. TVA 2023;24(1):278-94.

Benarous X, Renaud J, Breton J, et al. Are youths with disruptive mood dysregulation disorder different from youths with major depressive disorder or persistent depressive disorder? J Affect Disord 2020;265(3):207-15.

Sturm A, Rozenman M, Chang S, et al. Are the components of social reciprocity transdiagnostic across pediatric neurodevelopmental disorders? Evidence for common and disorder‐specific social impairments. Psychiatry Res 2018;264(7):119-23.

Pappadopulos E, Woolston S, Chait A, et al. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry 2006;15(1):27-39.

Cohen D, Raffin M, Canitano R, et al. Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: a Bayesian meta-analysis of efficacy and secondary effects. Res Autism Spectr Disord 2013;7(1):167-75.

Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004;114(5):634-41.

Breaux R, Baweja R, Eadeh HM, et al. Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for persistent nonepisodic irritability. J Am Acad Child Adolesc Psychiatry 2023;62(3):318-34.

Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorders. Pediatrics 2009;124(6):e1533-e1540.

Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH. Psychopharmacology and Aggression II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. J Emot Behav Disord 2003;11(3):157-68.

Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2011;158(7):1067-74.

Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 2000;157(5):818-20.

Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescent with conduct disorder. Arch Gen Psychiatry 2000;57(7):649-54.

Parmar A, Vats D, Parmar R, Aligeti M. Role of naltrexone in management of behavioral outbursts in an adolescent male diagnosed with disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol 2014;24(10):594-5.

Hendrickson B, Girma M, Miller L. Review of the clinical approach to the treatment of disruptive mood dysregulation disorder. Int Rev Psychiatry 2020;32(3):202-11.

MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56(12):1073-86.

Fernandez de la Cruz L, Simonoff E, McGough JJ, et al. Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: Results from the multimodal treatment study of children with ADHD (MTA). J Am Acad Child Adolesc Psychiatry 2015;54(1):62-70.

Baweja R, Belin PJ, Humphrey HH, et al.The effectiveness and tolerability of central nervous system stimulants in school-age children with attention-deficit/hyperactivity disorder and disruptive mood dysregulation disorder across home and school. J Child Adolesc Psychopharmacol 2016;26(2):154-63.

Winters DE, Fukui S, Leibenluft E, Hulvershorn LA. Improvements in irritability with open-label methylphenidate treatment in youth with comorbid attention deficit/hyperactivity disorder and disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol 2018;28(5):298-305.

Towbin K, Vidal-Ribas P, Brotman M.A, et al. A double-blind randomized placebo-controlled trial of citalopram adjunctive to stimulant medication in youth with chronic irritability. J Am Acad Child Adolesc Psychiatry 2019;59(3):350-61.

Cardinale EM, Freitag GF, Brotman MA, et al. Phasic versus tonic irritability: differential associations with ADHD symptoms. J Am Acad Child Adolesc Psychiatry 2021;60(12):1513-23.

Antisocial behaviour and conduct disorders in children and young people: recognition and management. London: National Institute for Health and Care Excellence (NICE); 2017.

Krieger FV, Pheula GF, Coelho R, et al. An open-label trial of risperidone in children and adolescents with severe mood dysregulation. J Child Adolesc Psychopharmacol 2011;21(3): 237-43.

Pan PY, Fu AT, Yeh CB. Aripiprazole/Methylphenidate combination in children and adolescents with disruptive mood dysregulation disorder and attention-deficit/hyperactivity disorder: An open label study. J Child Adolesc Psychopharmacol 2018;28(10):682-9.

Dickstein DP, Towbin KE, Van Der Veen JW, et al. Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol 2009;19(1):61-73.

Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics 2010;126(4): e796-e806.

Sukhodolsky DG, Smith SD, McCauley SA, Ibrahim K, Piasecka JB. Behavioral interventions for anger, irritability, and aggression in children and adolescents. J Child Adolesc Psychopharmacol 2016;26(1):58-64.

Waxmonsky JG, Waschbusch DA, Belin P, et al. A randomized clinical trial of an integrative group therapy for children with severe mood dysregulation. J Am Acad Child Adolesc Psychiatry 2016;55(3):196-207.

Kircanski K, Clayton M, Leibenluft E, Brotman M. Psychosocial treatment of irritability in youth. Curr Treat Options Psychiatry 2018;5(1):129-40.

Hommer RE, Meyer A, Stoddard J, et al. Attention bias to threat faces in severe mood dysregulation. Depress Anxiety 2014;31(7):559-65.

Stoddard J, Sharif-Askary B, Harkins EA, et al. An open pilot study of training hostile interpretation bias to treat disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol 2016;26(1):49-57.

Spring L, Carlson GA. The phenomenology of outbursts. Child Adolesc Psychiatr Clin N Am 2021;30(2):307-19.

Carlson GA, Chua J, Pan K, et al. Behavior modification is associated with reduced psychotropic medication use in children with aggression in inpatient treatment: A retrospective cohort study. J Am Acad Child Adolesc Psychiatry 2020;59(5):632-41.

Bardach NS, Doupnik SK, Rodean J, et al. ED visits and readmissions after follow-up for mental health hospitalization. Pediatrics 2020;145(6):e20192872.

James S, Charlemagne SJ, Gilman AB, et al. Post-discharge services and psychiatric rehospitalization among children and youth. Adm Policy Ment Health 2010;37:433-445.